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Proteins with try'vsin-like irnmunoreactivity (first detected by a specific immunoenzymatic assay) were isolated fr,~m CAPAN-  I ano CFPAC-  ! cell 
culture-condit ioned media by chromatography on an immunoadsorbem prepareo with a polyclonal antibody directed against trypsin I. The 
ad~ >r~e~ proteins were devoid o f  free trypsin activity but trypsin activity was present after enterokinas¢ activation den~onslrating that the 
imr,;~noreactive trypsin present in cell supernatants corresponds to trypsinogens. When characterised by Western blotting using a monoclonal 
antibody directed against human trypsin I two protein bands corresponding to trypsinogen I (23 kDa) and trypsinogen 2 (25 kDa) gave a positive 
reaction. These results demonstrate he presence of  trypsinogens ! and 2 in CAPAN- I  and CFPAC- I  cells and in their culture-conditioned media. 
Adenocarcinoma cell line; Pancre~';c; T~-y[-sinagen 
1. INTRODUCTION 
A new pancreat i c  adenocarc inoma ce i l  l i ne  (CFPAC-  
1) was  recent ly  es tab l i shed  f rom a pat ient  w i th  cys t i c  
f ib ros i s  (CF)  [1]. These  ce l l s  express  the  CF  gene  and  
man i fes t  the  most  common CF  mutat ion /de le t ion  o f  
th ree  nuc leot ides  resu l t ing  in  a Phe  s°8 de le t ion  (z lF  508)  
[2]. As  in  o ther  CF  secretory  ep i the l ia l  ce i l s ,  these  ce l l s  
a re  de fect ive  in cAMP-media ted  ac t ivat ion  o f  ap ica l  
membrane  channe ls ,  mak ing  th i s  ce l l  l i ne  use fu l  in the  
fu r ther  b iocEemica l  invest igat ion  o f  the  CF  de fect .  
S ince  a l te ra t ion  in  p ro te in  secret ion  has  a l so  been  de-  
sc r ibed  in  CF  ep i the l ia l  ce l l s  [3], we  looked  fo r  p ro te in  
n la rkers  secreted  by  CFPAC- I  ce l l s  p re l iminary  to  an  
invest igat ion  o f  p ro te in  secret ion  dysregu la t ion  in  CF .  
Recent  s tud ies  have  shown that  another  es tab l i shed  
human pancreat i c  carc inoma ce l l  l i ne ,  CAPAN- I ,  con-  
ta ined  a pept ide  s imi la r  o r  ident ica l  to  pancreat i c  se -  
c re tory  inh ib i to r  [4]. Because  proteases  and  the i r  in -  
h ib i to rs  usua l ly  occur  together ,  we  looked  fo r  the  pres -  
ence  o f  t ryps in - l i ke  pro te ins  in  ce l l  cu l tu re  supernatants  
o f  CAPAN- !  and  CFPAC=I .  Our  resu l t s ,  repor ted  in  
th i s  paper ,  demonst ra te  that  CAPAN-1  and  CFPAC- I ,  
but  not  o ther  tes ted  pancreat i c  ce l l  l i nes ,  secrete  the  two  
human pancreat i c  t ryps inogens .  
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2. MATERIALS  AND METHODS 
"2. i. Cell cultures 
2.1.1. CAPAN- I  and CFPAC- t  
The CFPAC- I  pancreatic adenocarcinoma cell line (passage 26) 
from a patient with cystic fibrosis (CF) was cultivated under Schou- 
rnacher's condit ions with s -~e modifications. Cells were grown on 
type I collagen-coated flasks (Falcon) in IMDM (l.,~ove's modified 
Dulbecco's medium, Sigma) st, pplemented with 5% decomplememed 
fetal bovine serum (Eurobio) in the presence of  100 U/ml penicillin and 
1O0 rag/rot streptomycin (Eurobio) and maintained at 37°C in a 5% 
CO:,/95% air atmosphere. Medium supernatants were removed every 
two days, collected and stored at -20°C ut~til use. Cells were usea~|y 
passaged every 8 days at 1:6 dilution by exposure to 0.05% trypsin in 
a 0.03% EDTA buffer at 37°C for 3 rain. The human pancreetic 
adenocarcinoma cell line CAPAI'4-1 (passage 74) was cultivated as 
CFPAC=I with the exception that the medium used was RPMi  1640 
(Sign,.a) instead of  IMDM.  Media supernatants were collected as 
described above and stored at -20°C.  
2. 1.2. Other pancreatic adenocarcinoma cell lines 
PANC- I .  obtained from the American Type Culture Collection 
(ATCC, Rockville, MD, USA) was cultured in Dulbecco's MEM with 
109b fetal bovine serum (F~S) at passage 72. CAPAN-2,  obtained 
from the ATCC, was cultured in McCoy's  5A media with 10% FBS 
at purge  36. ASPC- I ,  obtained from the ATCC, was cultured in 
RPMi  medium with 1095, FBS at indeterminate passage, and CD 1 !, 
kindly provided by Dr. Richard Metzgar o f  Duke University [5], was 
cultured in MEM with 10~ FBS at indeterm~rate passage. Medium 
supernatants were collected for two days and stored at -20°C before 
assays. 
2.2. DIqA analysis o f  the C,4PAN cell line with respect o lhe major CF 
nlutugio¢l 
The genotype of  CAPAN cell line with respect o the major CF  
mutation, (i.e. the Phe ~e deletion), was analysed by the heteroduplex 
method [6]. PCR-amplif ied DNA fragments panning the zIF 508 
position were generated using specific flanking primers (CF -16  B and 
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16 D)  as descr ibed by R io rdan  et al. {2]. No  hcterodup lex ,  wh ich  types  
heterozygosy  for  the mutat ion ,  was  observed  upon  gel e lectrophorests .  
M ix ing  the ampl i f ied CAPAN f ragments  with a cor respond ing  normal  
DNA f ragment  a lso did not  result  it, heterodup lcx  fo rmat ion ,  thus  
exc lud ing  a homozygous  state for  the LIF 50~; mutat ion .  F rom these 
data  we conc lude  that the  :IF 508 mutat ion  is absent  for both  CFTT  
alleles o f  the CAPAN- I  c¢11 line. 
2.3 Proteinx and antibodies 
Human t ryps inogens  I and  2 were part ia l ly  puri f ied by  chr' .~mato- 
g raphy  o f  human pancreat ic  ju ice on  DEAE-Tr i sacry l  M at p t t  8.0 in 
the  presence o f  I mM benzamid ine  and  l ima bean  tryps ln inh ib i to r  (5% 
o f  prote in  wt.)  as  prev ious ly  descr ibed [7 I. T ryps in  ! was  prepared  by 
autoaet ivat ion  o f  part ia l ly  puri f ied t ryps inogen I at pH 7.8 in the  
presence o f  20 mM ca lc ium,  and  pur i f icat ion by  aff in ity chromato -  
g raphy  on  Sepharose  coup led  w i th  aprot in in  (Bayer  AG)  as  prev ious ly  
descr ibed |8]. DFP- t ryps in  I was  obta ined  by incubat ion  o f  puri f ied 
trypsin I with 10 mM d i i sopropy l f lu rophosphate  ( I~FP)  10~-times 
molar  exCess) at pH 7.8 and  4°C for 24 h. Rabb i t  pel>,: lonal  ant ibod ies  
d irected aga inst  t ryps in  I were prepared  by in ject ion o f  puri f ied 
t ryps in 1. They  recognized both  trypsi ,~ogens I and  2 and  their  corre-  
spond ing  t ryps ins  (data  not  shown)  except  in the immunoassay  where  
on ly  t ryps in (ogen)  ! was  measured .  Monoc lona l  ant ibod ies  d i rected 
aga inst  t rypsin 1 were prepared  by immunisat ion  o f  OF~ mice wi th  
DFP- t ryps in  I and  hybr id i za t ion  o f  sp leen cells with mye loma cells in 
the cond i t ions  descr ibed e lsewhere  [9]- C lone  136, wh ich  recognizes  the 
two t ryps inogens  and  their  cor respond ing  t ryps ins ,  was  used.  
2.4. imenunoenzymatit" assays of  pancreatic encym¢,s 
Human t ryps in logen)  I was  measured  by a non-compet i t i ve  
"sandwich" enzyme immu noassay  as descr ibed in detai l  e lsewhere [ I 0]. 
Th is  immunoassay  does  not  recognize human t ryps inogen 2 o r  t ryps in  
f rom other  species. The  prese'aCe o f  chymotryps inogen and  l ipase in 
cu l ture  supernatants  was assayed  by specif ic non-compet i t i ve  enzyme 
immnnoassays  [ I I, 12]. 
2,5. Gel filtration experiments 
The  molecu la r  size distr ibuti~,n o f  immunoreact ive  t ryps in  ( IRT)  
present  in cu l ture  supernatant  was  determined  by a Sephadex  G I00  
SF  f i l tration in a 50 mM Tr i s -HC I  buf fer  conta in ing  200 mM NaC1 
at pH 7.6 ~nd 4°C. The  loaded sample  was  2 ml  and  the  col lected 
f ract ions  were ! ml  wi th  an  e lut ion rate o f  3 ml /h.  IRT  was measured  
in each  frg ction. Co lumn ca l ibrat ion  was  made witil the fo l lowing 
reference p:ote ins:  cy tochrome c (M,  12 5001 f rom F luka ;  chymotryp-  
s inogen A 25  0001, ova lbumin  (,15 000) and  bov ine  serum a lbumin  
166 000) f rcm Pharmac ia  F ine  Chemica ls .  
2.6. Immur.oudsorbent chromatography 
Immunc  g~obulin 4:/ ( lgG)  was  puri f ied by prec ip i tat ion o f  rabbi t  
immunserut~t  ant i - t ryps in  I with capryl ic  acid accord ing  to the tech- 
n ique  o f  S te inbuch  and  Audran  [13 i. l eg  was  fixed to act ivated 
Sepharose  (41 mg o f  leg  per  2 g o f  gel) fo l lowing the  method  o f  
Cuat reoasas  [14]. I~ fore  chromatography ,  400 ml  o f  cu l tu red  med ia  
were d ia lyzed overn ight  aga inst  0.05% NH,HCO3 and  concent ra ted  
by  lyophi l i sat ion.  Lyophi l i zed cu l ture  med ia  d isso lved in water  (15 rnl 
o fCFPAC-  ! and  17 ml  for  CAPAN-  ! ) were loaded  or, the  immunoad-  
sorbent  co lumn equi l ibrated in a 25 mM phosphate  buf fer ,  pH 7.0, 
conta in ing  I M NaCI .  Adsorbed  prote ins  were e luted by a 0.2 M 
g lyc ine-HCI  buf fer  at DH 2.5. The  e lut ion o f  immunoreact ive  t ryps in  
was  fo l lowed by  enzyme immunoassay .  
2.7. Western blotting 
Chromatograph ic  f rac t ions  were  concent ra ted  by  TCA precipi ta-  
t ion for  e ioutrophores is .  SDS-po lyacry la rn ide  gel e lec t rophores is  
fSDS-PAGE)  was  Imr formed a~x:o~ d ing  to Laemml i  [I $1 in von- rednc-  
ins  cond i t ions ,  in a 7 .5 - i  5~,  acry lamide  concent ra t ion -grad ient  s lab  
gel. A f te r  t rans fer  o f  p ro te ins  to n i t roce l lu lose as deser ib~!  by Bur -  
net te  [16]. immobi l i zed  pro te ins  were character i zed  by immunodetec -  
t ion us ing  monoc lona l  ant ibody  prepared  aga ins t  t ryps in  I. The  mon-  
o¢ lona l  ant ibody ,  wh ich  rt~:ognLr~-s bvth  human t ryps inogens ,  was  
d i lu ted {1:5901 i,~ phosphate  buf fered sal ine,  pH 8.0, conta in ing  10% 
new~born  ca l f  se rum and 0~2% Tr i ton  X I00 .  The  immune complexes  
were detected by a co lor  react ion  us ing  a second ant ibody  con jugated  
to horserad ish  perox idase  and  s ta in ing  with d iaminobeoz id ine  in the 
presence  o f  hydrogen perox ide,  as  descr ibed  by Coudr ic r  c ta l .  [17]. 
2.8. Aetivalion of  trypsmogen( s) b), emteroklnase 
lmmunoadsorbent  chromatograph ic  f ract i t .ns conta in ing  the 
h ighest  concent ra t ions  o f  immunoreaet ive  t ryps in  ! were poo led  and  
used for  act ivat ion.  A l iquots  (0.6 ml)  o f  t ryps inogen so lu t ion  (conta in -  
ing  72 ng and  257 ng  o f  immunorea~t ive  t ryps in  1 for  CAPAN- i  and  
CF~AC- I ,  respect ively)  were exposed  to enterok inase  (in excess  
amount )  in a T r i s -HC I  bu f fe r  at  pH 7.8 conta in ing  10 mM CaCI2 at 
aoc .  Samples  o f  th is  ac t ivat ion  mix ture  were removed per iod ica l ly  and  
t ryps in  act iv i ty  was  measured  by a spcet ro f luor imet r i c  method  us ing  
N-~-benzy ioxycarbony l -L -a rg in ine  (4 -methy l -T -coumary l )  amide  (10 
btM) as the enzyme suhst ra te ,  as  descr ibed  e lsewhere  [18]. 
2.9. Preparatio~ of cell lysates 
Cel ls  were r insed three  t imes  with a PBS  buf fe r  (Du lbeeco  A) and  
the]: incubated  in a 10 mM Tr i s -HC I  buf fer ,  pH 7.0. conta in ing  100 
mM NaCI  and  10 mM EDTA.  The  ~'¢lls were SCraped of f  and  sent -  
eared three  t imes  for  5 s at 4°C.  Prote in  concent ra t ion  was  measured  
accord ing  to Bradford  [19]. 
3.  RESULTS 
3 .1 .  Demons i ra t :on  o f  immunoreact ive  t ryps in I in 
CAPAN- I  and  CFPAC-1  cel l  l ines 
The  presence  o f  pancreat i c  enzymes  was  s tud ied  in  
the  supernatants  o f  6 ce l l  l i nes ,  PANC- I ,  CAPAN- I ,  
CAPAN-2 ,  CFPAC- i ,  ASPC- I  and  CD- I  1. No  immu-  
noreact ive  i ipase  and  chymotryps inogen was  detected  in  
any  ce l l  l i ne .  On ly  immunoreact ive  t ryps in  ! was  found  
in  CAPAN- I  and  CFPAC- I  supernatants  a t  the  leve l  o f  
10  ng /ml .  In  the  homogenates  o f  the  same ce l l  l i nes  
per fo rmed at  conf luency  (approx imate ly  5x106 ce l l s /25  
cm 21 immunoreact ive  t ryps in  1 concent ra t ion  was  4 _ 
2 ng /mg o f  p ro te in  in  both  ce l l  l i nes .  
3 .2 .  The molecu la r  s ize d is t r ibut ion o f  immut~oreact ive  
t ryps in  in cel l  cu l ture supernatant  
The  molecu la r  s i ze  d i s t r ibut ion  o f  immunoreact ive  
t ryps in  in  ce l l  cu l tu re  supernatant  was  determined  by  
immunoassay  o f  t ryps in  ~n the  d i f fe rent  f rac t ions  ob-  
ta ined  by  ge l  f i l t ra t ion .  Ident i ca l  p ro f i l es  were  observed  
fo r  CAPAN- I  and  CFPAC- i  supernatants  and  a typ ica l  
p ro f i l e  i s  p resented  in  F ig .  i .  F rac t ions  conta in ing  im-  
munoreact ive  t ryps in  i were  e lu ted  a t  the  end  o f  the  
second vo id  vo lume w i th  the  pro te ins  o f  25  kDa,  we l |  
separated  f rom the  genera l  p ro te in  peak .  Th is  e lu t ion  
pro f i l e  i s  cons i s tent  w i th  the  presence  o f  a fo rm o f  inac -  
t i ve  t ryps in ,  p robab ly  t ryps inogen,  in  the  supernatant .  
Ac t ive  t ryps in  shou ld  be  e lu ted  in  the  f i r s t  chromato -  
g raph ic  f rac t ions  as  complexes  assoc ia ted  w i th  serum 
inh ib i to rs .  
3 .3 .  I so lat ion o f  t ryps in- l ike  pro te ins  f rom CAPAN- I  
and  CFPAC- !  cel l  cu l ture  superna lant  bjv immu-  
t, oadsorbent  chromatography  
Tryps in - l i ke  pro te ins  were  i so la ted  by  immunoad-  
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F ig ,  i .  Ident i f i ca t ion  o f  the mc. lecutar fo rms o f  imtnunoreact ive  t ryps in  
( IRT)  by  gel  f i l t ra t ion  o f  (:=ell l ines" supernatant  on  Sephadex  G 100 
SF.  Co lumn ! .5 x 80 cm;  load ,  2 ml  o f  supcrnatant ;  f rac t ion  "volume, 
I mL  A 280 nm (17), IRT  (ram). 
sorbent  chromatography  on  an  a f f in i ty -co lumn o f  ant i -  
t ryps in  !. A f te r  d ia lys i s  and  concent ra t ion  by  lyoph i l i -  
sa t ion ,  cu l tu re  med ia  were  d i sso lved  in  water  and  
loaded on  the  immunoadsorbent  co lumn.  Adsorbed  
prote ins  were  e lu ted  by  ac id ic  pH and  immediate ly  
neut ra l i zed  at  pH 6.0 by  the add i t ion  o f  conven ient  
amounts  o fa  T r i s -HC l  bu f fe r  a t  pH 8.0. The  e lu t ion  was  
fo l lowed by  immunoenzymat ic  assay  wh ich  recogn ized  
on ly  t ryps in (ogen)  I ,  and  the  f rac t ions  conta in ing  im-  
rnunoreact ive  t ryps in  were  fu r ther  ana lysed  by  Western  
b lo t t ing .  
100-  , . . . .  
40 
2O 
0 . • , • , , , -  
T i m e  (rain) 
F ig .  3. Act iva l ion  o f  ce~l ines" superna lant  by  enterok inase .  Act iv i t ies  
wcr¢  ¢xpr~se~d in percent  o f  max imal  ac t iv i ty .  
3.4. Charac ler i :a t ion  o f  immunoreact ive  trypsin con- 
ta ined in CAPAN- I  and  CFPAC- I  cell  cul ture su- 
per~atant  
The co-naposit ior,  o f  t ryps in - l i ke  pro te ins  present  in 
cel l  supernatants  and  adsorbed  on  ant i - t ryps in  immu-  
noadsorbent  was  dcter rn ined  by Western  b lo t t ing .  The  
resu l ts  o f  the  immunodetect ion  w i th  the monoc lona l  
ant ibody  G6,  wh ich  recogn izes  both  human t ryps in -  
(ogcn)s ,  a re  shown in  F ig.  2. Two pos i t ive  react ions  are 
present  on  immunoreact ive  t ryps in -concent ra ted  frac-  
t ions  i so la ted  f rom CAPAN- I  supernatant .  The  prote in  
bands  cor respond to  the  reel .  wts. o f  23 and  25 kDa and  
are cons is tent  w i th  the  reel .  wts. of ,  resi~ectively, t ryps i -  
nogens  I and  2 pur i f ied  f rom human pancreat i c  ju ice  
[20]. The same resu l ts  were obta ined  w i th  immunoreac -  
t i re  t ryps in -concent ra ted  f rac t ions  i so la ted  f rom 









14  e 
Q 
Fi 8. 2. Western blotx of trypsinogens i olated from CAPAN-I ¢~il 
culture medlnn~. Refereru~ proteins (Std) us~i were: phosphorylasc 
b (94 kDa), bovine ~erum albumin (67 kDa), ovalbamin (43 kDa), 
carbonic anhydrase (30 kDa), soybean inhibitor (20 kDa) and a- 
htc~|bumin (14 kDa). Std proteins were s:ained with Ponceau S; 
trypslnogens (1"8) were immumodetected in CAPAN. and samples of  
TB! and Tg2. with a monoclonal ntibody to trypsin i. 
3.5. Enterok inase  act ivat ion o f  t ryps in- l ike prote ins  
The f rac t ions  w i th  the h ighest  immunoreact ive  
t ryps in  levels obta ined  by  immunoaf f in i ty  chromato-  
g raphy  o f  CAPAN-1  and  CFPAC- i  cel l  cu l ture -c :ond i -  
t ioned  med ia  were  poo led  and  assayed for  t ryps in  act iv -  
ity. These  f rac t ions  were  devo id  o f  t ryps in  act iv i ty  unt i l  
ac t ivated  by  enterok inase .  The  k inet ics  o f  ac t ivat ion  o f  
CAPAN-1  t ryps inogen is shown on  F ig .  3. T ryps in  ac-  
t iv i ty  reaches  a p la teau  a f ter  30 ra in  and  remains  s tab le  
for  3 h at  0°C .  The  same act ivat ion  was  obta ined  w i th  
CFPAC- I  t ryps inogen.  Th is  exper iment  demonst ra tes  
conc lus ive ly  that  immunoreact ive  t ryps in  present  in 
CAPAN- I  and  CFPAC- I  is in  the fo rm o f t ryps inogens .  
4. D ISCUSSION 
In  th is  s tudy ,  we demonst ra te  the express ion  o f  th© 
two human pancreat i c  t ryps inogens  in  two  human 
pancreat i c  cell l ines  CFPAC- i  and  CAPAN- I .  The  
normal  pancreat i c  g land  is composed o f  numerous  ex- 
ocr ine  and  endocr ine  cell types  wh ich  are  be l ;eved  to  
o r ig inate  f rom an  endodermic  s tem cell [21]. These  dif-  
fe rent  cell  types  do  not  seem to  have  the same ab i l i ty  to  
deve lop  tumors .  The  major i ty  (over  809b) o f  cancers  o f  
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exocr ine  pancreas  appear  to  a r i se  f rom ducta l  ep i -  
the l ium [22]. A l l  pancreat ic  ce i l  l ines s tud ied  in  th is  
repor t  have  been descr ibed  as  der iv ing  f rom tumors  o f  
pancreat ic  ducts .  F rom a l l  pancreat ic  ce l l  l i nes  exam-  
ined  here .  on ly  CAPAN- I  and  CFPAC- !  were  shown 
to  secrete  t ryp :~ inogens .  S ince  the  CFPAC-  1 ce l l  l i ne  has  
been es tab l i shed  f rom ~. pat ient  w i th  cys t i c  f ib ros i s  ho -  
mozygous  for  the common CF  mutat ion ,  we  first ex -  
c ludecl  the poss ib i l i ty  that  CAPAN- I  cou ld  unex-  
pected ly  present  the  same genotype .  The presence  o f  
o ther  CF  mutat ions  on  CAPAN- I  ce l l s  is not  to ta l ly  
exc luded but  it seems un l ike ly  that  a CF  mutat ion  was  
respons ib le  fo r  the  presence  o f  t ryps inogens .  The  poss i -  
b i l i ty  that  the  CAPAN-1  and  CFPAC- !  ce l l  l i nes  con-  
ta in  some ac inar  ce l l s  respons ib le  for  t ryps inogen syn-  
thes is  and  secret ion  a l so  seems to  be excruded,  s ince  
o ther  pancreat ic  enzymes  wel l  represented  in human 
externa l  secret ion ,  such  as chymotryps inogen and  
l ipase,  have  not  been  detected  in cu l tu re  supernatant  by  
sens i t ive  immunoenzymat ic  assays ,  even  af ter  a 10- fo ld  
concent ra t ion .  
D i f fe rent  poss ib i l i t i es  can  be suggested  to  exp la in  our  
f ind ings .  Neut ra l  p ro teases ,  ma in ly  p lasminogen act i -  
vator  [23] and  co l lagenases  [24], have  long  been thought  
to  be  invo lved  in the degradat ion  o f  ext race i lu la r  mat r ix  
and  tumor  invas ion .  The  recent  demonst ra t ion  o f  the 
express ion  o f  the  two human t ryps inogens  in cys t  f luid 
o f  mut inous  ovar ian  tumors  ind icate  a poss ib le  ro le  o f  
these  prote ins  in the  protease  cascade  in tur~tor invas io t :  
[25,26].  In  th is  respect  it is in teres t ing  to  note  that  the  
on ly  two  cel l  l ines produc ing  t r :~ps inogens  were  both  
es tab l i shed  f rom l iver  metastas i s  [ f ,27] .  On  the  o ther  
hand,  un l ike  the  o ther  pancreat ic  ce l l  l ines,  both  
CAPAN-1  and  CFPAC- I  ce l l s  spontaneous ly  fo rmed 
duct - l i ke  s t ruc tures  in the  s ta t ionary  phase  o f  g rowth .  
E lec t ron  micrographs  show ap ica l  mic rov i l l i  and  g lyco -  
ca lyx ,  subap ica l  cy top lasmic  vacuo les  conta in ing  muc in  
granu les  and  t ight  junct ions  between ad jacent  ce l l s  
[I ,28]. Dar ing  d i f fe rent ia t ion  in cu l tu re ,  CAPAN-  1 ce l l s  
were  shown to  fo rm domes  wh ich  are thought  to  be  the 
morpho log ica l  express ion  o f  t ransep i the l ia l  t ranspor t  o f  
water  and  e lec t ro ly tes  [29]. We observed  a s imi la r  dome 
format ion  o f  CFPAC- I  ce l l s  in cu l tu re  (unpub l i shed  
data) .  These  morpho log ica l  mod i f i ca t ions  suggest  a 
poss ib le  re la t ionsh ip  between the  presence  o f  t ryps i -  
nogens  and  a pecu l ia r  s tage  o f  pancreat ic  ducta l  cel l  
d i f fe rent ia t ion .  S inoe  recent  h i s to log ica l  f ind ings  have  
shown that  the  int ra-  and  in ter iobu lar  duct  ce l l s  o f  
o rgan  cu l tures  o f  human feta l  pancreas  s ta in  pos i t ive ly  
fo r  t ryps inogen (B .  Tuch ,  persona l  communicat ion) ,  the  
poss ib i l i ty  that  the  two neop las t i c  te l  l ines,  CAPAN- !  
and  CFPAC- I ,  have  regressed  back  to  a feta l  fo rm,  a 
feature  o f  so  many neop lasms,  is there fore  wor th  con-  
s ider ing .  
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